Ophthalmology Doctors in Wellesley, MA Accepting Medicare

5 Ophthalmology doctors found. Showing 1 - 5

Deborah S Eappen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 230 Worcester, Hvma/dept. Of Ophthalmology, Wellesley, MA 02481 Phone: 781-431-5265    Fax: 781-431-5235

Heidi Fischer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: One Washington Street, Suite 403, Wellesley, MA 02481 Phone: 781-235-5100    Fax: 781-235-2444

Dr. Elizabeth Daher, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 65 Walnut St, Suite 330, Wellesley, MA 02125 Phone: 781-235-1947    Fax: 781-642-7746

Robert J Mandel, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1 Washington St, Wellesley, MA 02481 Phone: 781-237-6770

Dr. Santiago Julio Villazon Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 40 Walnut St Ste 101, Wellesley, MA 02481 Phone: 617-796-3937    Fax: 617-796-3938

News Archive

Respected medical journal worried at lack of international cooperation in investigating scientific fraud

In a rather worrying development this week, prestige medical publication the British Medical Journal (BMJ) has expressed concern about the validity of a paper it published in 1992 written by Dr Ram B Singh of Moradabad, India.

Latest Breast cancer screening guidelines deemed unsafe by 80% women

Nearly 80 percent of women feel the new guidelines against breast cancer are unsafe as they stated that screening for those under 50 is not mandatory. The controversy over screening mammography flared up in late 2009, when a government-funded group of independent experts decided to change its recommendations. Instead of advising annual mammograms in all women age 40 and above, the U.S. Preventive Services Task Force (USPSTF) said women shouldn't routinely get screened until they hit 50, and those between 50 and 74 should only have mammograms every two years. But most of the women also seriously overestimate their risk of developing the disease, researchers from the University of Massachusetts Medical School in Worcester found.

FDA advisory committee recommends that FDA wait for overall survival results from Satraplatin phase 3 trial

GPC Biotech AG has announced that the Oncologic Drugs Advisory Committee (ODAC) for the U.S. Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial before deciding whether the satraplatin application is approvable for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.

Gene regulation rather than genes make us unique

Once the human genome was sequenced in 2001, the hunt was on for the genes that make each of us unique. But scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and Yale and Stanford Universities in the USA, have found that we differ from each other mainly because of differences not in our genes, but in how they're regulated - turned on or off, for instance.

Massachusetts receives $35.6 million HHS grant to develop online health care exchanges

The University of Massachusetts Medical School, the Massachusetts Executive Office of Health and Human Services and the Massachusetts Connector Authority have received a $35.6 million grant from the U.S. Department of Health and Human Services to develop an online "health care exchange," a resource through which consumers and small business owners can efficiently shop for health insurance plans.

Read more Medical News

› Verified 5 days ago